'It does put the #UK squarely into the prime market position – now both in terms of its large market size and the fact that it will likely be the quickest place to provide a legal path to market for #CBD#food, #drink and #supplement items.'
Very insightful piece from @CBDIntel.
Great piece in @Labiotech_eu on the rescheduling of #Epidyolex from Schedule 2 to Schedule 5, allowing much easier prescribing by doctors and access for patients.
This is a very important step for patients across the UK.
#cbd#ukcbd#cbduk
“This is the first time a cannabis-based medicine has been classified as a schedule 5 medicine."
CMC's Pharmacy Lead @DrAndyYates is quoted in this article covering the rescheduling of #Epidiolex.
https://t.co/AGJczcma1V
'Researchers on safety and toxicity confident of hitting UK deadlines'. Great piece in @CBDIntel. (Paywall)
https://t.co/XGXm0ZkIr5
#CBD#CBDUK#UKCBD#NovelFoods
'The @ACIndustry says it will lead a to study the safety of #CBD and decide the ingredient's recommended daily dose.'
Great piece by @OPWMorrison for @NutraEurope.
https://t.co/Wjjf4zPZ4F
#cbduk#ukcbd#novelfoods
For CBD companies who want to remain on that market next year thls is an important @ACIndustry event. Safety data generated from this study will be vital to meet novel foods dossier validation https://t.co/aOL7z193jq
'The message from the UK and around the world is the same; HCPs, regulators, and patients want access to robust data on the use of cannabis medicines to provide the evidence to confidently use these medicines appropriately and safely.
@SapphireClinics
https://t.co/MxjkxibYqq
I am on the panel at today's @cecf_eu, Medical Cannabis in Poland and CEE Online Conference Poland, 9th & 10th June.
Grab your ticket via this link
https://t.co/v8rrvDjUXp
#CBD#UKCBD#CBDUK
A big thank you to all the members that attended yesterdays @C4MC_UK's online In Conversation with @alfrep28. It was a very Insightful day with some fantastic questions put forward. Thank you to the day's chair, @DrAndyYates.
The @C4MC_UK are hosting an online discussion TODAY with myself and @MJBizDaily's International Analyst Alfredo Pascual (@alfrep28).
This is a free event for CMC members only.
Tickets here
https://t.co/yUgAgJZJX7
The @C4MC_UK are looking forward to hosting an online discussion with @MJBizDaily’s International Analyst @alfrep28 and CMC’s @DrAndyYates.
This is a free event for CMC members only is on 3rd June 2020.
https://t.co/rX3SnWOu0q
The @C4MC_UK are looking forward to hosting an online discussion with @MJBizDaily’s International Analyst @alfrep28 and CMC’s @DrAndyYates.
This is a free event for CMC members only is on 3rd June 2020.
https://t.co/rX3SnWOu0q
That was a brilliantly insightful afternoon. Thank you to all the panelists and all of the attendees for being there, and for all the fantastic questions that were put forward to the panelists.
@foodgov@CTSI_UK @HempIndDaily @MonicaRaymunt#CBD#NovelFoods#FSA#UKCBD#CBDUK
Last chance to grab your tickets for the @ACIndustry's #CBD#NovelFoods Virtual Symposium being held tomorrow.
Get them before 5pm today! 👇
https://t.co/BPWIexiBMc
Some real, official data about the medical cannabis market in the UK until February 2020
via @mjbizdailyintl w/ @DrAndyYates and @GrowPharmaUK
https://t.co/PgZqeorYmw
The @C4MC_UK in conversation with Alfredo Pascual, @alfrep28. Medical Cannabis in Europe: The Markets and Opportunities. Centre for Medicinal Cannabis.
3rd June 2020, 15:30-17:30 BST
Where: Online
Tickets: https://t.co/frwBvIm2mv
Our Pharmacy lead, @DrAndyYates told @alfrep28
at @MJBizDaily “ ‘specials’ medicines will always need to be prescribed appropriately and cautiously, our data at the CMC shows over 2% of the adult U.K. pop. are self-prescribing black-market cannabis.”
https://t.co/KO5l6tg8Qb
Our Pharmacy lead, @DrAndyYates told @alfrep28
at @MJBizDaily “ ‘specials’ medicines will always need to be prescribed appropriately and cautiously, our data at the CMC shows over 2% of the adult U.K. pop. are self-prescribing black-market cannabis.”
https://t.co/KO5l6tg8Qb
Our Pharmacy lead, @DrAndyYates told @alfrep28
at @MJBizDaily “ ‘specials’ medicines will always need to be prescribed appropriately and cautiously, our data at the CMC shows over 2% of the adult U.K. pop. are self-prescribing black-market cannabis.”
https://t.co/KO5l6sYxrB
Great piece featuring our Pharmacy Lead @DrAndyYates speaking to @alfrep28 of @MJBizDaily, "‘specials’ medicines will always need to be prescribed appropriately and cautiously, our data at the shows that over 2% of the adult U.K. pop. are self-prescribing black market #cannabis".